Navigation Links
Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
Date:5/20/2008

4.8 g/day dose using investigational 800 mg tablet demonstrated efficacy

and was well tolerated in ASCEND III study

SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- In a study presented today at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego, California, 70 percent of patients with moderately active ulcerative colitis (UC) receiving an investigational 800 mg mesalamine tablet dosed at 4.8 g/day under development by Procter & Gamble Pharmaceuticals experienced overall improvement in disease measures. In the study, the investigational tablet and dose were compared to 400 mg mesalamine tablets dosed at 2.4 g/day.

Additionally, patients in the study with a clinical history of more difficult-to-treat disease, such as those who have been previously treated with steroids and/or rectal therapies, received benefit from the investigational 800 mg tablets dosed at 4.8 g/day. Adverse events seen with the investigational 800 mg tablet dosed at 4.8 g/day were comparable to the 400 mg tablet dosed at 2.4 g/day and the discontinuation rate due to adverse events was no different between the two treatments (both 3.9 percent).

"The ASCEND III study is important because it helps us understand which patients may benefit from higher doses of mesalamine," says Dr. Stephen Hanauer, professor of medicine and clinical pharmacology chief, The University of Chicago Medical Center. "In this study the investigational 800 mg mesalamine tablet dosed at 4.8 g/day was well-tolerated and helped patients with moderately active UC manage their symptoms."

The ASCEND III study, which was discussed during an oral presentation at DDW today, was designed to further evaluate the clinical benefit of the investigational 800 mg tablet dosed at 4.8 g/day by assessing the non-inferiority of the 4.8 g/day dose versus the 2.4 g/day dose (400 mg mesalamine tablets). The primary endpoint was met -- the investigational 800 mg tablet dosed at 4.8 g/day w
'/>"/>

SOURCE Procter & Gamble
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
2. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
3. Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidones Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
4. Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation
5. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa
7. Cardiac Safety Study of Stinger S-200 Published
8. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
9. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
10. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
11. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...s and Marketing Efforts to Accelerate ... PARK, Calif., Oct. 9 /- Evalve, Inc.... percutaneous repair of cardiac valves,has expand... appointment of,Sean Cleary as senior vice preside...ardson, as vice president of sales., "The additio...
(Date:10/9/2008)...FirstCall/ -- Diamyd Medical reports,that the worl...and Journal,of Medicine, has published an article ...d(R) diabetes vaccine for type 1 diabetes., (Logo...7194 ), The article is now available on the jour... in print on October 30. It presents the,results o...
(Date:10/8/2008)...atments for Spinal Cord, Other Nerve,Injuries -, ...protein that enables,nerve cells to communicate wi...developing nervous system. Research into how that ...rve cells may provide a basis for eventual,treatme...ous system,including spinal cord injury., "This ...
(Date:10/8/2008)...sts Expand Testing Using Cellular ..., Oct. 8 /- Wild Blueberry antioxidan...lts from a new study,showing Wild Blueberries outp...ke apples, bananas, red grapes and strawberries in...ctivity (CAA) assay. New research,published in the...
Breaking Medicine Technology:Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3SportCoatings 3B The North American Booster Club Association 28NABCA 29 3B the Coatings Specialist Group New Booster Program Goes High Tech With Invi 149 1SportCoatings 3B The North American Booster Club Association 28NABCA 29 3B the Coatings Specialist Group New Booster Program Goes High Tech With Invi 149 2SportCoatings 3B The North American Booster Club Association 28NABCA 29 3B the Coatings Specialist Group New Booster Program Goes High Tech With Invi 149 3Weight Loss Surgeries Extend Lives 152 1Weight Loss Surgeries Extend Lives 152 2Weight Loss Surgeries Extend Lives 152 3Weight Loss Surgeries Extend Lives 152 4NYC area 1st 3A Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement 150 1NYC area 1st 3A Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement 150 2Restless legs syndrome affects nearly 2 percent of US UK children 135 1Restless legs syndrome affects nearly 2 percent of US UK children 135 2Restless legs syndrome affects nearly 2 percent of US UK children 135 3
... release broad range of clinical data on leading,d..., 2007 /PRNewswire-FirstCall/ -- Boston,Scientific...ompany,s major events and press announcements at t...CR), which will runs from May 22,to 25 in Barcelon...everal of our clinical,trials and registries, addi...
..., Calif.--(BUSINESS WIRE)--May 15, 2007 - Syntheti...ounced positive data from,a statistical analysis o... with traumatic brain injury. In line with prelimi...tistical results,confirmed that the primary endpoi...ompared with baseline was met. Data also show a,de...
Other Medicine Technology:Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...ed the G8 summit of the world's top industrialised..., warning that inaction would be costly. In a st...mm in Germany, Ban said the eight participating na... long-term global framework to tackle climate chan...
... womens insecurity about their body and their body...J. They believe that women should be warned about...lternative solutions to concerns about the appeara...hould be developed. More and more women are said ...
...s regularly investigated and debated for its impac... disease. Among its complex effects on the body, c... insulin and uric acid levels on a short-term basi...s suggest that coffee consumption may affect the r...
...ely low frequency electromagnetic fields, suggests...l and Environmental Medicine. The findings are ba... were monitored for 30 years. The researchers opt..., because railway workers in Switzerland tend to c...
Other Medicine News:Health News:Cosmetic Genital Surgery may Be Fuelling Womens Insecurity About Their Bodies 2Health News:Four Cups of Coffee a Day may Cut Down the Risk of Gout 2Health News:Four Cups of Coffee a Day may Cut Down the Risk of Gout 3
...MiniCorr Digital Hand-Held Pulse Oximeter provides... neonate to adult. The device is battery or AC po...ible and audible alarm signals, and an infrared li...r boot is also available for added protection. Th...
The FingerPrint Sleep Hand-Held Pulse Oximeter with built-in Summary Printer was specifically designed for sleep screening studies in the sleep lab, clinical environment, or home. With its easy-to-u
The BCI 3180 Pulse Oximeter is a cost-effective, stand-alone monitor that delivers fast, reliable SpO 2 pulse rate and pulse strength measurements of patients from neonate to adult. This AC or batt
...U.S. Food and Drug Administration (FDA) has grante...ens (IOL) for cataract patients with and without p...ry apodized diffractive technology to give patient...te and distance) that greatly increases their inde...
Medicine Products: